Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating everolimus in de novo renal transplant recipients participating in the Eurotransplant Senior Program was terminated, and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Afinitor (everolimus)
• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 4 | Status: TERMINATED | Results posted: 2014-05-12